Over recent years we have run a number of popular workshops and seminars discussing the development of faecal immunochemical testing and the growing evidence for its benefits in detecting bowel disease. See below for video recordings of presentations from experts in the field plus Q and A sessions with the audience.
ACB Focus, 2018
ACB Focus, Alpha Laboratories sponsored a workshop: ‘FIT to Practice?’ which was chaired by Professor Callum Fraser and presented by Nigel D’Souza and Sally Benton.
Nigel D’Souza presented preliminary data on the NICE FIT study which aims to recruit 5,500 patients from London, to evaluate the diagnostic accuracy of FIT particularly in diverse populations. In tandem with this, the study aims to better understand the limitations of FIT and recognise the potential effects of indiscriminate use. With the announcement of NICE DG30 in July 2017, the NICE FIT study has grown significantly and begun to recruit patients in non-London hospitals: it is anticipated this additional data will provide NHS England a stronger evidence based against which to make future recommendations. The testing is done by Sally Benton, Director of the Southern Bowel Cancer Screening Hub, and her team, who are conducting research into the analytical side of FIT.